Respiratory Infections

Latest News

How Molnupiravir Affects COVID-19 Recovery Time, Risk of Hospitalization and Death
How Molnupiravir Affects COVID-19 Recovery Time, Risk of Hospitalization and Death

March 20th 2023

Despite failing to meet primary trial endpoints, molnupiravir reduced the length of COVID-19 infection by 4.2 days in vaccinated patients.

Raising Awareness About RSV in Older Adults
Raising Awareness About RSV in Older Adults

March 17th 2023

Omicron XBB.1.5: Heightened Transmissibility, Infectivity, and Immune Resistance
Omicron XBB.1.5: Heightened Transmissibility, Infectivity, and Immune Resistance

March 16th 2023

GSK Achieves Primary Endpoints Meningococcal ABCWY Vaccine for Phase 3 Trial
GSK Achieves Primary Endpoints Meningococcal ABCWY Vaccine for Phase 3 Trial

March 15th 2023

Cardiovascular Disease and Death More Likely in COVID-19 Survivors
Cardiovascular Disease and Death More Likely in COVID-19 Survivors

March 13th 2023

Video Series
Video Interviews
Podcasts

More News

© 2023 MJH Life Sciences

All rights reserved.